Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Intelicare Holdings Limited (ICR.AX)
AUD0.02
+0.00 (+4.76%)
AU ASX Healthcare Medical - Healthcare Information Services
Address
299 Vincent Street 6007
Leederville, WA, AU
Leederville, WA, AU
CEO
Daniel Pilbrow
Website
intelicare.com.au
IPO
2020-05-25
ISIN AU0000081788
Also trades on
Australian Securities Exchange · ICR.AX (AUD)
NASDAQ Global Select · ICR (USD)
New York Stock Exchange · ICR-PA (USD)
Description
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Australia's aged care and health industries. Among its key offerings are InteliLiving, tailored to assist seniors and individuals with disabilities, and a specialized monitoring system designed for the elderly and other vulnerable populations.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD0.02
+0.00 (+4.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
430.2K
Beta
0.54
Float Shares
271.54M
Free Float %
57.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.70% | +0.00% | +0.00% | +25.00% | -3.85% | +4.17% | +257.14% | +66.67% | -88.77% | -90.91% | -90.91% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.02
Quality scores
Altman Z-Score
-23.01
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+241.3% ★ Q4'25: +299.2% (vs Q4'23)
-
EPS growth Medical - Healthcare Information Services: +43.1%+51.0% ★ Q4'25: +22.6% (vs Q4'23)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-198.1% Q4'25: -315.0% (vs Q4'23)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-226.6% Q4'25: -261.9% (vs Q4'23)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q4'25: +2,834.2% (vs Q4'23)
-
Share dilution Medical - Healthcare Information Services: -0.1%+101.9% Q4'25: +167.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.33× Q4'25: -0.22× (vs Q4'23)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2026 1 Rev. Ana. |
Jun 2027 1 Rev. Ana. |
Jun 2028 1 Rev. Ana. |
Jun 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
267.5K
est: 100.0K (+167.5%)
|
363.1K
est: 800.0K (-54.6%)
|
429.8K
est: 2.10M (-79.5%)
|
404.3K
est: 6.40M (-93.7%)
|
100.0K
100.0K – 100.0K
-98.4% YoY
|
800.0K
800.0K – 800.0K
+700.0% YoY
|
2.10M
2.10M – 2.10M
+162.5% YoY
|
6.40M
6.40M – 6.40M
+204.8% YoY
|
| EBITDA |
-2.49M
est: -100.0K (-2,389.3%)
|
-4.24M
est: -800.0K (-430.1%)
|
-3.78M
est: -2.10M (-79.8%)
|
-2.89M
est: -6.40M (+54.8%)
|
-100.0K
-100.0K – -100.0K
+98.4% YoY
|
-800.0K
-800.0K – -800.0K
-700.0% YoY
|
-2.10M
-2.10M – -2.10M
-162.5% YoY
|
-6.40M
-6.40M – -6.40M
-204.8% YoY
|
| EBIT |
-2.55M
est: -100.0K (-2,453.0%)
|
-4.36M
est: -800.0K (-444.8%)
|
-3.93M
est: -2.10M (-87.2%)
|
-2.98M
est: -6.40M (+53.5%)
|
-100.0K
-100.0K – -100.0K
+98.4% YoY
|
-800.0K
-800.0K – -800.0K
-700.0% YoY
|
-2.10M
-2.10M – -2.10M
-162.5% YoY
|
-6.40M
-6.40M – -6.40M
-204.8% YoY
|
| Net Income |
-2.55M
|
-4.36M
|
-3.93M
|
-3.00M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| SGA |
2.16M
est: 476.8K (+353.9%)
|
2.91M
est: 3.81M (-23.6%)
|
2.08M
est: 10.01M (-79.2%)
|
1.72M
est: 30.52M (-94.4%)
|
476.8K
476.8K – 476.8K
-98.4% YoY
|
3.81M
3.81M – 3.81M
+700.0% YoY
|
10.01M
10.01M – 10.01M
+162.5% YoY
|
30.52M
30.52M – 30.52M
+204.8% YoY
|
| EPS |
-0.05
|
-0.05
|
-0.03
|
-0.02
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.18M
OE per share TTM
-0.01
Owner's Yield
-29.58%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
24.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-2.7K
Shares Outstanding
472.73M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Tappenden | Chief Technology Officer | 313.6K | male |
| Daniel Pilbrow | Chief Executive Officer | 312.2K | male |
| Neil John Hackett BECON GAICD GDAFI GDFP | Company Secretary | 55.5K | male |
| Gregory David Leach | Founder & Non-Executive Director | 46.3K | male |
| Pieter Klopper | Chief Financial Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ICR.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
